ChemicalBook >> CAS DataBase List >>Detumomab

Detumomab

Detumomab structure

CAS No.: 145832-33-3

Chemical Name:: Detumomab

Synonyms: Detumomab;Research Grade Detumomab;Research Grade Detumomab (DHK11001)

CBNumber:: CB51118169

Molecular Formula:

Molecular Weight:: 0

MDL Number:

MOL File:: Mol file

TDS File:: TDS

Last updated:2026-04-24 14:58:57

Request For Quotation

Detumomab Properties

FDA UNII	8Z3Q8X4UAD

Detumomab Chemical Properties,Uses,Production

Uses

Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma. Detumomab can be used in the research of cancers such as non-Hodgkin's lymphoma (NHL).

Detumomab Preparation Products And Raw materials

Raw materials

Preparation Products

Detumomab Suppliers

Global( 11)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Beijing HuaMeiHuLiBiological Chemical	010-56205725	waley188@sohu.com	China	12335	58
Shanghai Han-Xiang Chemical Co., Ltd.	15971444841 17754423994	candy@biochempartner.com	China	3061	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10308	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9865	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11972	58
Atagenix Laboratories	027-87008169 17762441161	info@atagenix.com	China	9998	58
AntibodySystem Laboratories SAS	--	support@antibodysystem.com	China	6738	58
Biosynth Biological Technology (Suzhou) Co Ltd	--	sales@biosynth.com	China	6051	58
Guangzhou Chuangze Biotechnology Co., Ltd.	--		CHINA	6078	58

Supplier	Advantage
Beijing HuaMeiHuLiBiological Chemical	58
Shanghai Han-Xiang Chemical Co., Ltd.	58
Wuhan Chemstan Biotechnology Co., Ltd.	58
Biolab Reagents	58
Shanghai Yifei Biotechnology Co. , Ltd.	58
Atagenix Laboratories	58
AntibodySystem Laboratories SAS	58
Biosynth Biological Technology (Suzhou) Co Ltd	58
Guangzhou Chuangze Biotechnology Co., Ltd.	58

145832-33-3(Detumomab)Related Search:

Xeligekimab Siplizumab Briakinumab Mavezelimab Bertilimumab

Porgaviximab Trinbelimab Cilgavimab Lymphocide Tibulizumab

1of2

Detumomab Research Grade Detumomab (DHK11001) Research Grade Detumomab 145832-33-3